Navigation Links
Frost & Sullivan Applauds Check-Cap for Pioneering a Non-invasive, Prep-Free Wireless Capsule Endoscope
Date:11/11/2013

MOUNTAIN VIEW, Calif., Nov. 11, 2013 /PRNewswire/ -- Based on its recent analysis of the wireless capsule endoscopes market, Frost & Sullivan recognizes Check-Cap Ltd. with the 2013 European Frost & Sullivan Award for New Product Innovation Leadership.

Check-Cap's capsule device, also named Check-Cap, is based on a novel imaging approach that enables the 3D virtual reconstruction of the colon, eliminating the need for bowel preparation. The imaging capsule, which resembles a vitamin capsule in its size and shape, is easy to swallow and is designed to wirelessly transmit data to a small receiver that is no bigger than a disposable patch on the patient back.

Wireless capsules need to satisfy the requirement of the two key stakeholders in the market the patients and the physicians. From the perspective of the patient, the capsule has to do away with, or at least significantly ease the most bothersome aspect of the current screening procedure, namely, bowel preparation. They also have to be small enough for easy oral administration and unhindered mobility through the gastrointestinal track. From the physician's perspective, it should provide 360-degree visualization and cover the colon comprehensively in both quality and quantity. Check-Cap checks both these boxes and is peerless in its efficiency.

"While competing products strive for a 360-degree view of the colon by adopting multiple cameras and either fall short or risk image overlaps and redundancy, Check-Cap has adopted an X-ray platform that not only enables a 360-degree view, but also obtains information that is 'hidden' or inaccessible to other products that employ rays of visible light," said Frost & Sullivan Research Analyst Bhargav Rajan.

Although wireless capsule endoscopes are more comfortable than traditional endoscopes for the patient, they suffer from incomplete imaging of the colon due to lack of maneuverability. To combine the best of both wireless and traditional endoscopes, Check-Cap uses X-ray Radar technology, which emits X-rays through the device's surface in all directions. The X-ray data that is backscattered and captured by the capsule detectors, is then converted, post-procedure, to 3D images of the colon's internal surfaces. X-rays, unlike light rays, can pass through solid content and tissues. This feature allows physicians to perform the procedure without an uncomfortable and prolonged colon cleansing procedure and detect polyps that are not visible to other capsule endoscopes.

Check-Cap is currently undergoing clinical trials in Europe and is planning to submit the request to initiate an efficacy study in North America late next year. Like other routine radiographic diagnosis of the gastrointestinal tract, Check-Cap requires a barium-swallow pre-procedure to help differentiate the colon structure from the content.

The X-Radar technology also maximizes the critical diagnostic time available to the physician, while the 3D reconstruction of the colon facilitates accurate diagnosis. Check-Cap not only eliminates the redundancy caused by multiple cameras, but also ensures that there is little or no chance of images being left out or not captured through insufficient coverage.

"Check-Cap estimates a review time of 7 to 10 minutes to be sufficient for physicians to identify clinically significant polyps and prescribe a follow-up accordingly," noted Rajan. "X-ray Radar technology not only differentiates the Check-Cap product from its competitors, but is also designed to match classical colonoscopy in its clinical accuracy."

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value added features/benefits of the product and the increased ROI it offers customers, which, in turn, increases customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Check-Cap Ltd.

Check-Cap is a clinical-stage medical device company focused on the development of gastrointestinal imaging devices. Check-Cap is developing a proprietary screening methodology that combines the safety of pill endoscopy and the resolution of optical methodologies while eliminating the need for aggressive preparation of the patient bowel prior to screening.

Check-Cap believes its technology represents a breakthrough in providing an effective structural exam without the pain, discomfort and embarrassment experienced by patients undergoing traditional colonoscopy and other currently available capsule endoscopy.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

Guy Neev
P: 972.54.800.6200
E: guyn@check-cap.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016  Aralez Pharmaceuticals Inc. ("Aralez") today announced the ... Tribute Pharmaceuticals Canada Inc. ("Tribute") following approval of the ... The combined company will operate under Aralez Pharmaceuticals Inc. ... Canada , Ireland ... Under the terms of the Agreement and Plan of ...
(Date:2/5/2016)... , Feb. 5, 2016  Venice,s newest laser ... the first of its kind in the area ... through advanced laser treatment. The physician-owned and operated ... Suncoast by storm with its revitalizing skin ... advanced multi-wavelength Astanza Trinity technology. http://photos.prnewswire.com/prnh/20160204/329957 ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology:
(Date:2/6/2016)... St. Petersburg, FL (PRWEB) , ... February 06, 2016 , ... ... AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Belly ... rug. If having tried everything from sprays to puppy pads and find nothing works, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... ... 05, 2016 , ... Successful recruitment and retention efforts, new ... initiatives have all marked the last 12 months at Roswell Park Cancer Institute ... nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... announce the addition of micro-needling services in their Napa Valley office. The technique ... of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
Breaking Medicine News(10 mins):